P. Nystrom

发表

Factor XIII Val 34 Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease

M. Vatta, D. Flockhart, Z. Desta, 2014 .

Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease

M. Vatta, D. Flockhart, Z. Desta, 2014, Journal of Thrombosis and Thrombolysis.

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel

D. Flockhart, Z. Desta, R. Kreutz, 2015, Platelets.

Early clinical investigation of Viozan (sibenadet HCl), a novel D2 dopamine receptor, beta2-adrenoceptor agonist for the treatment of chronic obstructive pulmonary disease symptoms.

P. Ind, L. Laitinen, P. Nystrom, 2003, Respiratory medicine.

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response

Lang Li, R. Kovacs, D. Flockhart, 2013, Clinical pharmacology : advances and applications.

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

R. Kovacs, D. Flockhart, Z. Desta, 2013, Platelets.

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Lang Li, R. Kovacs, D. Flockhart, 2012, Clinical pharmacology : advances and applications.

Reverse assembly of a double-lumen tube.

P. Nystrom, 2003, Anesthesia and analgesia.

Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids

P. Nystrom, Christopher Chan, D. DeLapp, 2016, Respiratory medicine case reports.

Pilot Study in the Use of Human Patient Simulator (HPS) as a Novel Approach to COPD Self-Management

D. Sampsel, R. Gauder, P. Nystrom, 2014 .

Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma

P. Nystrom, Christopher Chan, D. DeLapp, 2016, Respiratory medicine case reports.